trastuzumab deruxtecan,abiraterone
astrazeneca,janssen,daiichi sankyo
['abiraterone', 'prostate', 'pcsm', 'cyclone-3', 'abira']
at #esmo22, we re sharing the trial in progress poster of cyclone-3, a global phase 3 trial investigating if pts w/ high-risk metastatic hormone-sensitive #prostatecancer benefit from addition of a cdk4 &amp; 6 inhibitor to abiraterone. #pcsm learn more: 
Dedicated to communicating the latest science & innovation from Loxo@Lilly. Tweets intended for US oncology HCPs. See our community guidelines: https://t.co/1q8vAe63mK